Etid klinik pou Gliyòm nan Minnesota
13 etid pou Gliyòm ap chèche patisipan nan sit nan Minnesota.
Vil nan Minnesota
Tèks ofisyèl etid la (Anglè)
Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07025226A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Ap rekriteFaz 1/2
12 Months – 21 Years · Tout sèks · Mizajou Oct 1, 2026 · NCT05099003SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Rochester, Rochester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Minnesota, Minneapolis
Ap rekriteFaz 1
Laj 1 a 25 · Tout sèks · Mizajou Aug 18, 2026 · NCT04485559Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
- Mayo Clinic in Rochester, Rochester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT04047264A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Rochester, Rochester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07074756A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- St. Luke's Hospital, Duluth
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07468136Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- Mayo Clinic, Rochester
Ap rekriteFaz 1/2
Laj 19 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06011109Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Cancer Center, Rochester
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06482905Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT05717153CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
- Children's Minnesota, Minneapolis
Ap rekriteFaz 1
Laj 2 a 25 · Tout sèks · Mizajou Mar 12, 2024 · NCT06305910Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.